Biodesix, Inc. (BDSX)
14.17
-0.59
(-4.00%)
USD |
NASDAQ |
May 15, 16:00
14.14
-0.03
(-0.21%)
After-Hours: 20:00
Biodesix Total Liabilities (Quarterly) : 85.50M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Interpace Biosciences, Inc. | 10.33M |
| GRAIL, Inc. | 302.79M |
| FONAR Corp. | 54.77M |
| Thermo Fisher Scientific, Inc. | 61.22B |
| Innovative MedTech, Inc. | 1.303M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 94.64M |
| Shareholders Equity (Quarterly) | 9.132M |
| Debt to Equity Ratio | 7.842 |
| Current Ratio | 2.824 |
| Net Debt Paydown Yield | -1.67% |